HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness company offering premium probiotic supplements and products containing CBD, has unveiled its new CBD gummy line. Formulated using HempFusion’s proprietary broad-spectrum hemp extract, never an isolate, the new gummies feature natural functional ingredients and premium flavors. The Elderberry CBD Immune Support Gummies include 10 mg of broad-spectrum CBD and 100 mg of elderberry extract, a functional ingredient scientifically studied to support the immune system. HempFusion’s sweet-and-tart Summer Cherry Gummies feature 10 mg of best-in-class broad spectrum CBD in a delicious chew. According to a recent Brightfield Group report, the CBD gummy market is projected to reach $500 million in sales this year, with a forecast of $1.8 billion sales by 2026. In another report, Brightfield reported that immune-boosting benefits were the second most popular health claim that consumers look for when purchasing food, beverage and supplement products. In recent marketing, the gummies have been recommended by two-time Olympic Gold medalist and five-time world champion women bobsled athlete Kaillie Humphries. “Now available from HempFusion.com, our gummy line is our newest revenue driver and is now shipping to major food, drug and mass retail and convenience locations with further distribution planned across international markets as well as ecommerce sites,” said HempFusion Wellness CEO Jason Mitchell, ND, in the press release. “We welcome consumers to learn more and try our delicious new Elderberry CBD Immune Support and Summer Cherry Gummies for themselves by visiting HempFusion.com. Use code Gummyrush25 to enjoy 25% off plus free shipping through Sept. 4, 2021.”
To view the full press release, visit https://ibn.fm/cTr1D
About HempFusion Wellness Inc.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in stores or online. For more information about the company, visit www.HempFusion.com.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.